NEW YORK (GenomeWeb) – Thermo Fisher Scientific announced this week that it has completed its $4.2 billion acquisition of electron microscopy company FEI. Thermo Fisher paid $107.50 per share in cash. FEI will become part of Thermo Fisher's analytical instruments business unit.


Agilent Technologies said this week that its board has approved a quarterly dividend of $.12 per share of common stock, to be paid on Oct. 26, to all shareholders of record as of Oct. 4.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.